~~<i id='D7819154C0'><strike id='D7819154C0'><tt id='D7819154C0'><pre id='D7819154C0'></pre></tt></strike></i>~~

Home» comprehensive» Wikipedia

Wikipedia

author：entertainment 2025-10-02 03:51:05 Page View：2

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn
Next article： As demand for Covid shots wanes, Moderna seeks its next success

explore

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

1:00PresidentialcandidateFernandoVillavicenciospeaksduringacampaigneventataschoolminutesbeforehewass

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Pharma budget tightening trickles down to Doximity

AdobeYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Sign